US FDA warns Ranbaxy arm
Ranbaxy's US unit Ohm Laboratories has received a warning letter from the US Food and Drug Administration (FDA), about violating manufacturing practices at its plant.
The Times of India,
Thu Dec 24 12:47:16 PST 2009
• Found on Yahoo! News
Outsourcing steroid for Indian pharma firms
Thanks to such deals, these drug companies are now well poised to post growth in excess of 20 per cent every year for the next five to 10 years, say industry analysts.
rediff.com,
Sun Dec 20 20:59:06 PST 2009
• Found on Yahoo! News